Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
Dae-Won LeeSae-Won HanYongjun ChaJeong Mo BaeHwang-Phill KimJaemyun LyuHyojun HanHyoki KimHoon JangDuhee BangJae-Kyung WonSeung-Yong JeongKyu Joo ParkGyeong Hoon KangTae-You KimPublished in: BMC cancer (2019)
Mutation in genes within TGF-β pathway may have negative prognostic role for SAR in CRC. Other pathway mutations were not associated with SAR.